Lana Hamieh

Medicine & Life Sciences

1. Tuberous Sclerosis 100%
2. Renal Cell Carcinoma 77%
3. Mosaicism 26%
4. Epilepsy 23%
5. Ipilimumab 20%
6. Electroencephalography 17%
7. Neoplasms 15%
8. Autism Spectrum Disorder 14%
9. Therapeutics 13%
10. Seizures 12%
11. Everolimus 12%
12. lenvatinib 12%
13. Sunitinib 11%
14. Mutation 11%
15. Survival 11%
16. Genes 11%
17. Meningeal Carcinomatosis 11%
18. Angiofibroma 10%
19. Neoplasm Metastasis 9%
20. Child 9%
21. Middle East 9%
22. Breast Neoplasms 9%
23. Poly(ADP-ribose) Polymerase Inhibitors 9%
24. Cell-Free Nucleic Acids 9%
25. Gene Frequency 8%
26. Cancer Pain 8%
27. Pharmacogenetics 8%
28. Inborn Genetic Diseases 8%
29. Metformin 7%
30. Neoplastic Stem Cells 7%
31. Brain 7%
32. Microcirculation 7%
33. Melanoma 7%
34. Plasma Cells 7%
35. Magnetic Resonance Imaging 7%
36. Phenotype 7%
37. Cytochrome P-450 CYP3A 6%
38. DNA Repair 6%
39. Aspirin 6%
40. Cohort Studies 6%
41. Immunotherapy 6%
42. Tertiary Care Centers 6%
43. Clinical Trials 6%
44. Prospective Studies 6%
45. Single Nucleotide Polymorphism 6%
46. DNA 6%
47. Publications 6%
48. Drug Resistant Epilepsy 6%
49. Databases 6%
50. Vigabatrin 5%